6.4M Pfizer COVID-19 Vaccine Doses To Be Distributed Across US Within 24 Hours Of FDA Approval: WaPoBenzinga • 11/25/20
With 2 Effective Coronavirus Vaccine Candidates, How Should Investors Proceed?The Motley Fool • 11/23/20
Decision on approving Pfizer-BioNTech vaccine to be made in ‘shortest time possible,' U.K. regulator saysMarket Watch • 11/23/20
Pfizer Doses First Participant in Phase 3 Study Evaluating anti-TFPI Investigational Therapy, Marstacimab, for People With Severe Hemophilia A and B With or Without InhibitorsBusiness Wire • 11/23/20
Why Ultra-Cold Storage and Two-Dose Shots Could Spell A Logistical Nightmare for PfizerThe Motley Fool • 11/22/20